Risk Factors Associated With an Impaired Antibody Response in Kidney Transplant Recipients Following 2 Doses of the SARS-CoV-2 mRNA Vaccine

BACKGROUND. Data about vaccine efficacy in solid organ transplant patients are limited. We previously reported our initial observation of a 6.2% immunogenicity rate in kidney transplant recipients (KTRs) after administration of 1 dose of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-...

Descripción completa

Detalles Bibliográficos
Autores principales: Yi, Stephanie G., Moore, Linda W., Eagar, Todd, Graviss, Edward A., Nguyen, Duc T., Ibrahim, Hassan, Huang, Howard J., Hobeika, Mark, McMillan, Robert, Saharia, Ashish, Mobley, Constance, Podder, Hemangshu, Drews, Ashley, Ghobrial, R. Mark, Gaber, A. Osama, Knight, Richard J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Kidney Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670582/
https://www.ncbi.nlm.nih.gov/pubmed/34912946
http://dx.doi.org/10.1097/TXD.0000000000001257

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670582/
https://www.ncbi.nlm.nih.gov/pubmed/34912946
http://dx.doi.org/10.1097/TXD.0000000000001257

Ejemplares similares